Intervention

AMG 133

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions4

Lead sponsors shown1

Clinical trials

4 shown

The Effect of AMG 133 on Gastric EmptyingNCT07429032 · 2025-04-17

A Trial to Assess the Effect of Kidney Impairment on How AMG 133 is Absorbed, Broken Down, and Eliminated by the BodyNCT07429045 · 2025-03-11

A Trial to Evaluate Interactions Between Antiemetic Medication and AMG 133 in Participants Living With Overweight or ObesityNCT07310563 · 2024-12-10

A Study to Evaluate AMG 133 Administered Subcutaneously in Participants With Overweight or ObesityNCT06976372 · 2024-08-20

Common conditions

Obesity2 Overweight2 Overweight and Obesity1 Overweight or Obesity1

Leading sponsors

Trial status mix

COMPLETED4

Phase mix

PHASE14

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.